Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > Luvhorses ur posts always read like a pissy drunk wrote it.

<< Previous

Bullboard Posts

Next >>

Comment by luvhorseson Sep 01, 2020 10:18am

94 Views

Post# 31486024

RE:Luvhorses ur posts always read like a pissy drunk wrote it.

Hey Big A....I'm sensing a lot of anger and hostility in your voice! I don't think it's directed at me but rather at the share price...can't blame y'a!!

AGN is going down while others (t.FVL and v.AVG, v.AMK, ) have gone up...where will you be at the closing bell today??

.26, .27???

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market